• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bridging the Gap between Dermatology and Psychiatry: A Review on Quality of Life in Trichotillomania and Special Considerations in Management.弥合皮肤科与精神科之间的差距:拔毛癖患者生活质量综述及管理中的特殊考量
Skin Appendage Disord. 2024 Dec;10(6):463-469. doi: 10.1159/000539563. Epub 2024 Jul 15.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Patient navigator programmes for children and adolescents with chronic diseases.慢性病患儿和青少年的患者导航员计划。
Cochrane Database Syst Rev. 2024 Oct 9;10(10):CD014688. doi: 10.1002/14651858.CD014688.pub2.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Interventions for interpersonal communication about end of life care between health practitioners and affected people.干预健康从业者与受影响者之间关于临终关怀的人际沟通。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD013116. doi: 10.1002/14651858.CD013116.pub2.

本文引用的文献

1
Microneedling as an adjunctive treatment for trichotillomania.微针疗法作为拔毛癖的辅助治疗方法。
Dermatol Ther. 2022 Nov;35(11):e15824. doi: 10.1111/dth.15824. Epub 2022 Sep 23.
2
Prevalence and gender distribution of trichotillomania: A systematic review and meta-analysis.拔毛癖的患病率和性别分布:系统评价和荟萃分析。
J Psychiatr Res. 2022 Sep;153:73-81. doi: 10.1016/j.jpsychires.2022.06.058. Epub 2022 Jul 1.
3
Dramatic Improvement of Trichotillomania with 6 Months of Treatment With N-Acetylcysteine.使用N-乙酰半胱氨酸治疗6个月后拔毛癖显著改善。
Glob Pediatr Health. 2022 Mar 14;9:2333794X221086576. doi: 10.1177/2333794X221086576. eCollection 2022.
4
Trichotillomania: What Do We Know So Far?拔毛癖:我们目前了解多少?
Skin Appendage Disord. 2022 Jan;8(1):1-7. doi: 10.1159/000518191. Epub 2021 Sep 1.
5
Natural recovery in trichotillomania.拔毛癖的自然缓解。
Aust N Z J Psychiatry. 2022 Oct;56(10):1357-1362. doi: 10.1177/00048674211066004. Epub 2021 Dec 14.
6
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.斑秃:发病机制、诊断和治疗的最新进展。
Clin Rev Allergy Immunol. 2021 Dec;61(3):403-423. doi: 10.1007/s12016-021-08883-0. Epub 2021 Aug 17.
7
Sex Differences in Age at Onset and Presentation of Trichotillomania and Trichobezoar: A 120-Year Systematic Review of Cases.拔毛癖和毛粪石发病年龄及临床表现的性别差异:120年病例系统综述
Child Psychiatry Hum Dev. 2022 Feb;53(1):165-171. doi: 10.1007/s10578-020-01117-y. Epub 2021 Jan 8.
8
Common causes of hair loss - clinical manifestations, trichoscopy and therapy.脱发的常见原因——临床表现、毛发镜检及治疗
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):629-640. doi: 10.1111/jdv.17079. Epub 2021 Jan 8.
9
Comorbidity in trichotillomania (hair-pulling disorder): A cluster analytical approach.拔毛癖(毛发 pulling 障碍)共病:聚类分析方法。
Brain Behav. 2019 Dec;9(12):e01456. doi: 10.1002/brb3.1456. Epub 2019 Nov 6.
10
Trichotillomania (hair pulling disorder).拔毛癖(拔毛障碍)。
Indian J Psychiatry. 2019 Jan;61(Suppl 1):S136-S139. doi: 10.4103/psychiatry.IndianJPsychiatry_529_18.

弥合皮肤科与精神科之间的差距:拔毛癖患者生活质量综述及管理中的特殊考量

Bridging the Gap between Dermatology and Psychiatry: A Review on Quality of Life in Trichotillomania and Special Considerations in Management.

作者信息

Onyemachi Jane, Nguyen Caroline, Nguyen Lynchi, Chukwuma Olivia, Muñoz-Gonzalez Ayezel

机构信息

John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, TX, USA.

Department of Dermatology, The University of Texas Medical Branch, Galveston, TX, USA.

出版信息

Skin Appendage Disord. 2024 Dec;10(6):463-469. doi: 10.1159/000539563. Epub 2024 Jul 15.

DOI:10.1159/000539563
PMID:39659654
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11627546/
Abstract

BACKGROUND

Trichotillomania (TTM), also known as hair pulling disorder, is a chronic disorder that often leads to considerable emotional distress and functional impairment in affected individuals. Despite the strong underlying psychiatric component of TTM, the majority of individuals suffering from TTM initially may present to dermatologists because of their hair loss. This necessitates awareness and early recognition of TTM as well as familiarity with the unique considerations for its management.

SUMMARY

This study reviews the limited literature regarding quality of life in TTM, the methodologies employed to assess quality of life, and further explores the necessity of an interdisciplinary clinical approach to treatment. Several studies included in this review demonstrated the significant degree to which TTM reduces quality of life. Multiple treatment modalities for TTM have been successfully used in the literature that incorporate a comprehensive approach to management and ultimately address the underlying psychiatric component of TTM.

KEY MESSAGES

TTM significantly reduces the quality of life in affected individuals. Successful management of TTM requires an interdisciplinary approach that bridges dermatology and psychiatry. Screening tools that assess the impact of TTM on quality of life are clinically useful and essential for early diagnosis and optimal management.

摘要

背景

拔毛癖(TTM),也称为拔毛障碍,是一种慢性疾病,常常给受影响的个体带来相当大的情绪困扰和功能损害。尽管拔毛癖有很强的潜在精神病理学成分,但大多数拔毛癖患者最初可能因脱发而就诊于皮肤科医生。这就需要认识并尽早识别拔毛癖,以及熟悉其治疗的特殊注意事项。

总结

本研究回顾了关于拔毛癖患者生活质量的有限文献、用于评估生活质量的方法,并进一步探讨了跨学科临床治疗方法的必要性。本综述纳入的几项研究表明,拔毛癖对生活质量有显著影响。文献中已成功使用多种治疗拔毛癖的方法,这些方法采用综合管理方式,最终解决拔毛癖的潜在精神病理学成分。

关键信息

拔毛癖显著降低了受影响个体的生活质量。成功治疗拔毛癖需要跨学科方法,将皮肤科和精神科联系起来。评估拔毛癖对生活质量影响的筛查工具在临床上有用,对早期诊断和优化管理至关重要。